Low Frequency of DNMT3A Mutations in Pediatric AML, and the Identification of the OCI-AML3 Cell Line as an in Vitro Model

Leukemia - United Kingdom
doi 10.1038/leu.2011.210
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cell Line OCI/AML3 Bears Exon-12 NPM Gene Mutation-A and Cytoplasmic Expression of Nucleophosmin

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Dominating the Negative: How DNMT3A Mutations Contribute to AML Pathogenesis

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2017English

The Combination of NPM1, DNMT3A and IDH1/2 Mutations Leads to Inferior Overall Survival in AML

American Journal of Hematology
Hematology
2019English

Prognostic Relevance of DNMT3A R882 Mutations in AML Patients Undergoing Non-Myeloablative Conditioning Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2018English

The EOL-1 Cell Line as an in Vitro Model for the Study of FIP1L1-PDGFRA-positive Chronic Eosinophilic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

DNMT3A Mutations in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Regulation of the Acute Myeloid Leukemia Cell Line OCI/AML-2 by Endothelial Nitric Oxide Synthase Under the Control of a Vascular Endothelial Growth Factor Signaling System

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Establishment of an in Vitro Chicken Epithelial Cell Line Model to Investigate Eimeria Tenella Gamete Development

Parasites and Vectors
ParasitologyInfectious Diseases
2018English

MOVAS-1 Cell Line: A New in Vitro Model of Vascular Calcification

International Journal of Molecular Medicine
MedicineGenetics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy